Literature DB >> 10943279

Identification of the sentinel node in patients with breast cancer.

S H Parker1, M A Dennis, T I Kaske.   

Abstract

Sentinel node analysis represents a significant advance in the diagnosis and treatment of invasive breast cancer. The traditional crude method of full axillary dissection for assessing the status of the axillary nodes can now be discarded in favor of the much more elegant and modern approach of minimally invasive sentinel node analysis and its attendant elimination of the morbidity of traditional axillary node dissection. The many impediments to and pitfalls in the technique of sentinel node analysis, however, must be recognized and overcome for the procedure to be reliable and consistently successful. The use of ultrasound and a smaller particle size can help overcome many of these pitfalls. Because ultrasound identification of the axillary sentinel node in patients with invasive breast cancer is possible, it may allow for percutaneous excision of these nodes in the future (Fig. 8). Combining percutaneous excision and ablation of the primary breast carcinoma with percutaneous excision of the sentinel node allows for the nonsurgical treatment of small breast cancers in the future. The modern breast radiologist should be at the forefront of these advances.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10943279     DOI: 10.1016/s0033-8389(05)70202-5

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  2 in total

1.  Breast cancer diagnosis: what are we waiting for?

Authors:  P Rasuli
Journal:  CMAJ       Date:  2001-08-07       Impact factor: 8.262

Review 2.  Axillary lymph node echo-guided fine-needle aspiration cytology enables breast cancer patients to avoid a sentinel lymph node biopsy. Preliminary experience and a review of the literature.

Authors:  Vittorio Altomare; Gabriella Guerriero; Rita Carino; Cleonice Battista; Angelo Primavera; Annamaria Altomare; Donata Vaccaro; Alessandro Esposito; Anna Maria Ferri; Carla Rabitti
Journal:  Surg Today       Date:  2007-08-27       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.